Home » Stocks » INVO

INVO Bioscience, Inc. (INVO)

Stock Price: $3.11 USD -0.02 (-0.64%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $3.08 -0.03 (-0.81%) Jan 22, 7:55 PM
Market Cap 29.64M
Revenue (ttm) 1.17M
Net Income (ttm) -5.30M
Shares Out 4.95M
EPS (ttm) -0.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $3.11
Previous Close $3.13
Change ($) -0.02
Change (%) -0.64%
Day's Open 3.10
Day's Range 3.02 - 3.12
Day's Volume 25,432
52-Week Range 2.98 - 3.42

News

There are no news available yet.

About INVO

INVO Bioscience, a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipme... [Read more...]

Industry
Medical Devices
Founded
2007
CEO
Steven M. Shum
Employees
5
Stock Exchange
NASDAQ
Ticker Symbol
INVO
Full Company Profile

Financial Performance

In 2019, INVO's revenue was $1.48 million, an increase of 199.41% compared to the previous year's $494,375. Losses were -$2.17 million, -29.54% less than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.38, which is an increase of 73.27% from the latest price.

Price Target
$5.38
(73.27% upside)
Analyst Consensus: Buy